TGFB1 and neoplasm: In ER- models, specific blockade of tumoral Smad-mediated TGFβ signaling [22,24,27,28] reduces osteolytic ER- BMET size in combination with a reduction in tumor-associated osteoclasts, thus revealing a key pathogenic role for tumoral TGFβ signaling in osteolysis.